ARTICLE | Company News
Edge Therapeutics, SurModics deal
July 26, 2010 7:00 AM UTC
The companies signed a feasibility agreement under which SurModics will develop a biodegradable, site-specific, sustained-release formulation of the generic calcium channel blocker nimodipine to prev...